Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 4,009-4,020 of 10,592
Drug study icon
CompletedNCT02978599

study of AVL-3288 in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00349973

study of Dipyridamole in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT04846868

study of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-1)

This study exists to learn from real-world information that can show how the medication Iclepertin fits into care. Researchers are trying to understand whether the medication Iclepertin can improve attention, thinking, or day-to-day functioning.

In United States
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Australia, Canada, ...
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Drug study icon
CompletedNCT04846881

study of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

This study exists to learn from real-world information that can show how the medication Iclepertin fits into care. Researchers are trying to understand whether the medication Iclepertin can improve attention, thinking, or day-to-day functioning.

In United States
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, France, Argentina, ...
Sponsor
Boehringer Ingelheim
Condition
Schizophrenia
Drug study icon
CompletedNCT00043654

study of Mifepristone for Depression in bipolarity

This study exists to see whether the medication Mifepristone is workable and worth testing more broadly. Researchers are trying to understand whether the medication Mifepristone can improve attention, thinking, or day-to-day functioning.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity, Depression
Drug study icon
CompletedNCT00025792

study of Pramipexole in Depression in bipolarity

This summary needs review. Please check the official study record and contact the research team for details.

In United States
Bipolarity, DepressionDrug
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Bipolarity, Depression
Behavioral study icon
CompletedNCT02656745

study of Smoking Cessation Mobile Phone Program

This summary needs review. Please check the official study record and contact the research team for details.

Remote / online
AddictionBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.